logo-loader

Proactive news highlights: featuring Angus Energy, Deltex Medical, Anglo Pacific and more…

Published: 16:10 18 Jan 2017 GMT

newspapers

Deltex Medical Group plc (LON:DEMG) has started to see revenue from its blood flow monitoring probes rise again as US sales pick up strongly.

Income from probes (used in patients in surgery or recovery) rose 4% over the year to £5.4mln and by 10% to £3.1mln in the second half.

Elsewhere, Angus Energy Plc (LON:ANGS) has given investors an update on its operation onshore UK at the Brockham field where it is about to start the re-entry of an existing well bore.

The company, in a concise statement, said that work to upgrade the existing well’s infrastructure (production bungs) are now complete.

In the next few days it expects to start the re-entry, it then anticipates to complete and case the well in around two to three days.

Anglo Pacific Group PLC (LON:APF TSX:APY) has reaped the full benefit of coal prices hitting a five-year high.

Royalty income in 2016 will be 140% higher and in a range of £20.5mln - £21.5mln (2015: £8.7m), the company said.

An increase in saleable tonnes at the Rio Tinto operated Kestrel mine in Australia also boosted the numbers.

In other news, vehicle tracking group Quartix Holdings plc (LON:QTX) has told investors that it expects to report better-than-expected revenues when it releases its 2016 full-year results next month.

The Newtown-based company added that profits for the year are on track to meet expectations.

Summit Therapeutics PLC (LON:SMM, NASDAQ:SMMT) has hired Dr David Roblin as its new chief operating officer and president of research and development.

The drug developer, which is advancing therapies for Duchenne muscular dystrophy (DMD), told investors that Roblin will lead research and development functions, as well as commercial functions, to support the development of the DMD and CDI programmes.

Life sciences group OptiBiotix Health plc (LON:OPTI) is bringing on board an experienced sales and marketing director to help create new revenue streams for OptiBiotix’s pipeline of products.

Christina Wood will join the team in due course subject to the completion of the normal regulatory due diligence, Opti said.

And finally, Ariana Resources plc (LON:AAU)  has been quick to remind investors that it owns a huge chunk of land in Turkey close to the Hot Maden project being developed by Mariana Resources (LON:MARL) and Lidya.

A scoping study for Hot Maden released yesterday suggested a net present value of around US$1.4bn for the project.

FTSE rises ahead of Easter weekend, JD Sport gains on upbeat outlook -...

The FTSE 100 gained on the final morning of this shortened Easter trading week. Festive cheer was limited though, as Thames Water confirmed shareholders would not provide it with a £500 million rescue package, prompting speculation over the London supplier’s future. On a more positive...

55 minutes ago